These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 18475180

  • 1. Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1.
    Jiang J, Salido EC, Guha C, Wang X, Moitra R, Liu L, Roy-Chowdhury J, Roy-Chowdhury N.
    Transplantation; 2008 May 15; 85(9):1253-60. PubMed ID: 18475180
    [Abstract] [Full Text] [Related]

  • 2. Phenotypic correction of a mouse model for primary hyperoxaluria with adeno-associated virus gene transfer.
    Salido E, Rodriguez-Pena M, Santana A, Beattie SG, Petry H, Torres A.
    Mol Ther; 2011 May 15; 19(5):870-5. PubMed ID: 21119625
    [Abstract] [Full Text] [Related]

  • 3. Feasibility of hepatocyte transplantation-based therapies for primary hyperoxalurias.
    Guha C, Yamanouchi K, Jiang J, Wang X, Roy Chowdhury N, Santana A, Shapiro LJ, Salido E, Roy-Chowdhury J.
    Am J Nephrol; 2005 May 15; 25(2):161-70. PubMed ID: 15849463
    [Abstract] [Full Text] [Related]

  • 4.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, Milliner DS, Harris PC, Sas DJ, Cogal AG, Lieske JC.
    ; 1993 May 15. PubMed ID: 20301460
    [Abstract] [Full Text] [Related]

  • 5. Systemic Alanine Glyoxylate Aminotransferase mRNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1.
    Kukreja A, Lasaro M, Cobaugh C, Forbes C, Tang JP, Gao X, Martin-Higueras C, Pey AL, Salido E, Sobolov S, Subramanian RR.
    Nucleic Acid Ther; 2019 Apr 15; 29(2):104-113. PubMed ID: 30676254
    [Abstract] [Full Text] [Related]

  • 6. Generation of a Primary Hyperoxaluria Type 1 Disease Model Via CRISPR/Cas9 System in Rats.
    Zheng R, Fang X, He L, Shao Y, Guo N, Wang L, Liu M, Li D, Geng H.
    Curr Mol Med; 2018 Apr 15; 18(7):436-447. PubMed ID: 30539697
    [Abstract] [Full Text] [Related]

  • 7. Combined liver-kidney transplantation in primary hyperoxaluria type 1.
    Cochat P, Gaulier JM, Koch Nogueira PC, Feber J, Jamieson NV, Rolland MO, Divry P, Bozon D, Dubourg L.
    Eur J Pediatr; 1999 Dec 15; 158 Suppl 2():S75-80. PubMed ID: 10603104
    [Abstract] [Full Text] [Related]

  • 8. Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene.
    Li Y, Zheng R, Xu G, Huang Y, Li Y, Li D, Geng H.
    Am J Physiol Renal Physiol; 2021 Mar 01; 320(3):F475-F484. PubMed ID: 33491567
    [Abstract] [Full Text] [Related]

  • 9. Generation of induced pluripotent stem cells-derived hepatocyte-like cells for ex vivo gene therapy of primary hyperoxaluria type 1.
    Estève J, Blouin JM, Lalanne M, Azzi-Martin L, Dubus P, Bidet A, Harambat J, Llanas B, Moranvillier I, Bedel A, Moreau-Gaudry F, Richard E.
    Stem Cell Res; 2019 Jul 01; 38():101467. PubMed ID: 31151050
    [Abstract] [Full Text] [Related]

  • 10. Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology.
    Estève J, Blouin JM, Lalanne M, Azzi-Martin L, Dubus P, Bidet A, Harambat J, Llanas B, Moranvillier I, Bedel A, Moreau-Gaudry F, Richard E.
    Biochem Biophys Res Commun; 2019 Oct 01; 517(4):677-683. PubMed ID: 31402115
    [Abstract] [Full Text] [Related]

  • 11. Human MiR-4660 regulates the expression of alanine-glyoxylate aminotransferase and may be a biomarker for idiopathic oxalosis.
    Tu X, Zhao Y, Li Q, Yu X, Yang Y, Shi S, Ding Z, Miao Y, Zou Z, Wang X, Jiang J, Du D.
    Clin Exp Nephrol; 2019 Jul 01; 23(7):890-897. PubMed ID: 30852714
    [Abstract] [Full Text] [Related]

  • 12. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter.
    Hatch M, Gjymishka A, Salido EC, Allison MJ, Freel RW.
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar 01; 300(3):G461-9. PubMed ID: 21163900
    [Abstract] [Full Text] [Related]

  • 13. Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer.
    Salido EC, Li XM, Lu Y, Wang X, Santana A, Roy-Chowdhury N, Torres A, Shapiro LJ, Roy-Chowdhury J.
    Proc Natl Acad Sci U S A; 2006 Nov 28; 103(48):18249-54. PubMed ID: 17110443
    [Abstract] [Full Text] [Related]

  • 14. [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].
    van Woerden CS, Groothof JW, Wanders RJ, Waterham HR, Wijburg FR.
    Ned Tijdschr Geneeskd; 2006 Jul 29; 150(30):1669-72. PubMed ID: 16922352
    [Abstract] [Full Text] [Related]

  • 15. In vivo base editing rescues primary hyperoxaluria type 1 in rats.
    Chen Z, Zhang D, Zheng R, Yang L, Huo Y, Zhang D, Fang X, Li Y, Xu G, Li D, Geng H.
    Kidney Int; 2024 Mar 29; 105(3):496-507. PubMed ID: 38142039
    [Abstract] [Full Text] [Related]

  • 16. Identification of compound heterozygous patients with primary hyperoxaluria type 1: clinical evaluations and in silico investigations.
    Kanoun H, Jarraya F, Maalej B, Lahiani A, Mahfoudh H, Makni F, Hachicha J, Fakhfakh F.
    BMC Nephrol; 2017 Oct 02; 18(1):303. PubMed ID: 28969594
    [Abstract] [Full Text] [Related]

  • 17. Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1.
    Castello R, Borzone R, D'Aria S, Annunziata P, Piccolo P, Brunetti-Pierri N.
    Gene Ther; 2016 Feb 02; 23(2):129-34. PubMed ID: 26609667
    [Abstract] [Full Text] [Related]

  • 18. Further studies on the activity and subcellular distribution of alanine:glyoxylate aminotransferase in the livers of patients with primary hyperoxaluria type 1.
    Danpure CJ, Jennings PR.
    Clin Sci (Lond); 1988 Sep 02; 75(3):315-22. PubMed ID: 3416563
    [Abstract] [Full Text] [Related]

  • 19. Molecular analysis of the AGXT gene in patients suspected with hyperoxaluria type 1 and three novel mutations from Turkey.
    Isiyel E, Ezgu SA, Caliskan S, Akman S, Akil I, Tabel Y, Akinci N, Ozdogan EB, Ozel A, Eroglu FK, Ezgu FS.
    Mol Genet Metab; 2016 Dec 02; 119(4):311-316. PubMed ID: 27915025
    [Abstract] [Full Text] [Related]

  • 20. [Primary hyperoxaluria: A review].
    Bouzidi H, Majdoub A, Daudon M, Najjar MF.
    Nephrol Ther; 2016 Nov 02; 12(6):431-436. PubMed ID: 27372182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.